Quest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer


Werte in diesem Artikel
Aktien

208.20 EUR 1.60 EUR 0.77 %

SECAUCUS, N.J., May 6, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, announced today that Murali Balakumar, a veteran information technology healthcare business leader, has been named Senior Vice President and Chief Information and Digital Officer (CIDO).

Murali Balakumar, Senior Vice President and Chief Information and Digital Officer

Mr. Balakumar, based at the company's headquarters in Secaucus, N.J., is responsible for leading information technology, data informatics and digital solutions for Quest Diagnostics.

"Murali is a digital transformation leader with 25 years of experience designing and implementing technology strategy in the healthcare, financial services and transportation industries," said Mr. Davis. "He brings deep expertise in leading high-performance global teams and steering the design and delivery of large-scale, complex technology solutions. I'm pleased to welcome Murali to the Quest team."

Prior to joining Quest, Murali was Chief Information Officer at Oak Street Health, which was acquired by CVS Health in 2023. Prior to Oak Street, Murali was Chief Information Officer for Card Services at Fiserv and has also held IT leadership roles at JPMorgan Chase Bank and General Electric.

Mr. Balakumar earned a bachelor's degree in engineering from the Indian Institute of Technology in Chennai, India; a master's in engineering from the University of Texas; and an MBA from the University of Chicago.

About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of deidentified clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com.

Quest Diagnostics Incorporated logo. (PRNewsFoto/Quest Diagnostics Incorporated)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-names-murali-balakumar-senior-vice-president-and-chief-information-and-digital-officer-302136774.html

SOURCE Quest Diagnostics

Aktuelle Quest Diagnostics Aktie News

Werbung

Quest Diagnostics Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Quest Diagnostics nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
Datum Rating Analyst
25.06.18 Quest Diagnostics Overweight Barclays Capital
20.10.17 Quest Diagnostics Buy Mizuho
25.07.17 Quest Diagnostics Buy Mizuho
05.06.17 Quest Diagnostics Buy Mizuho
12.05.17 Quest Diagnostics Hold Argus Research Company

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.